3.0.0 2296 2022-11-01T19:47:14Z 2022-11-01T19:47:14Z House HR 2019-04-12 116 [Congressional Record Volume 165, Number 64 (Friday, April 12, 2019)][House]From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]By Ms. SCHAKOWSKY:H.R. 2296.Congress has the power to enact this legislation pursuantto the following:Article I, Section 8, Clause 3The Congress shall have Power . . . To regulate Commercewith foreign Nations, and among the several States, and withthe Indian Tribes.[Page H3265]]]> hsif00 Energy and Commerce Committee House Standing hsif14 Health Subcommittee Reported by 2019-07-11T20:05:59Z Markup by 2019-07-11T20:05:53Z Hearings by 2019-05-21T20:33:34Z Referred to 2019-04-15T16:43:23Z Reported by 2019-09-24T19:36:14Z Markup by 2019-07-17T15:07:53Z Referred to 2019-04-12T18:32:50Z H. Rept. 116-215 Elijah E. Cummings Lower Drug Costs Now Act 116 3 HR 2020-09-08 Read the second time. Placed on Senate Legislative Calendar under General Orders. Calendar No. 521. Related bill CRS Lower Costs, More Cures Act of 2019 116 19 HR 2019-12-19 Referred to the Subcommittee on Antitrust, Commercial, and Administrative Law. Related bill CRS Drug Price Transparency Act 116 2087 HR 2019-05-21 Subcommittee Hearings Held. Related bill CRS Public Disclosure of Drug Discounts and Real-Time Beneficiary Drug Cost Act 116 2115 HR 2019-10-29 Received in the Senate and Read twice and referred to the Committee on Finance. Related bill CRS Prescription Pricing for the People Act of 2019 116 2376 HR 2019-05-21 Subcommittee Hearings Held. Related bill CRS Medicare for America Act of 2019 116 2452 HR 2019-05-31 Referred to the Subcommittee on Courts, Intellectual Property, and the Internet. Related bill CRS Shop Rx Act of 2019 116 3408 HR 2019-06-24 Referred to the Subcommittee on Health. Related bill CRS Real-Time Beneficiary Drug Cost Bill 116 3415 HR 2019-06-24 Referred to the Subcommittee on Health. Related bill CRS Prescription Pricing for the People Act of 2019 116 1227 S 2019-06-28 Placed on Senate Legislative Calendar under General Orders. Calendar No. 131. Related bill CRS Fair Accountability and Innovative Research Drug Pricing Act of 2019 116 1391 S 2019-05-09 Read twice and referred to the Committee on Health, Education, Labor, and Pensions. Related bill CRS Lower Health Care Costs Act 116 1895 S 2019-07-08 Placed on Senate Legislative Calendar under General Orders. Calendar No. 133. Related bill CRS Strengthening Average Sales Price Reporting Act of 2019 116 2051 S 2019-06-28 Read twice and referred to the Committee on Finance. Related bill CRS To amend the Health Information Technology for Economic and Clinical Health Act to require the Secretary of Health and Human Services to consider certain recognized security practices of covered entities and business associates when making certain determinations, and for other purposes. 116 7898 HR 2021-01-05 Became Public Law No: 116-321. Related bill CRS 2019-09-24 Placed on the Union Calendar, Calendar No. 170. Calendars H12410 2 House floor actions U00170 2019-09-24 Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 116-215. Committee H12200 2 House floor actions hsif00 Energy and Commerce Committee 2019-09-24 Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 116-215. Committee 5000 9 Library of Congress hsif00 Energy and Commerce Committee 2019-07-17 hsif00 Energy and Commerce Committee 1 House committee actions Ordered to be Reported (Amended) by Voice Vote. Committee 2019-07-17 hsif00 Energy and Commerce Committee 1 House committee actions Committee Consideration and Mark-up Session Held. Committee 2019-07-11 hsif14 Health Subcommittee 1 House committee actions Forwarded by Subcommittee to Full Committee (Amended) by Voice Vote . Committee 2019-07-11 hsif14 Health Subcommittee 1 House committee actions Subcommittee Consideration and Mark-up Session Held. Committee 2019-05-21 hsif14 Health Subcommittee 1 House committee actions Subcommittee Hearings Held. Committee 2019-04-15 hsif14 Health Subcommittee 1 House committee actions Referred to the Subcommittee on Health. Committee 2019-04-12 Referred to the House Committee on Energy and Commerce. IntroReferral H11100 2 House floor actions hsif00 Energy and Commerce Committee 2019-04-12 Introduced in House IntroReferral Intro-H 9 Library of Congress 2019-04-12 Introduced in House IntroReferral 1000 9 Library of Congress S001145 Rep. Schakowsky, Janice D. [D-IL-9] JANICE SCHAKOWSKY D IL D. 9 N R000607 Rep. Rooney, Francis [R-FL-19] Francis Rooney R FL 19 2019-04-12 True D000399 Rep. Doggett, Lloyd [D-TX-35] LLOYD DOGGETT D TX 35 2019-07-12 False S001168 Rep. Sarbanes, John P. [D-MD-3] John Sarbanes D MD P. 3 2019-07-12 False U000040 Rep. Underwood, Lauren [D-IL-14] Lauren Underwood D IL 14 2019-07-12 False G000568 Rep. Griffith, H. Morgan [R-VA-9] H. Griffith R VA Morgan 9 2019-07-18 False S001201 Rep. Suozzi, Thomas R. [D-NY-3] Thomas Suozzi D NY R. 3 2019-08-20 False P000607 Rep. Pocan, Mark [D-WI-2] Mark Pocan D WI 2 2019-09-19 False C001103 Rep. Carter, Earl L. "Buddy" [R-GA-1] Earl Carter R GA L. "Buddy" 1 2019-09-19 False 2019-09-18T13:29:00Z H.R. 2296, METRIC Act https://www.cbo.gov/publication/55637 As ordered reported by the House Committee on Energy and Commerce on July 17, 2019 Health Civil actions and liability Congressional oversight Consumer affairs Corporate finance and management Government information and archives Government studies and investigations Inflation and prices Medical research Prescription drugs Research and development Health 00 2019-04-12 Introduced in House 2021-02-10T17:55:51Z Fair Accountability and Innovative Research Drug Pricing Act of 2019 or the FAIR Drug Pricing Act of 2019

This bill requires manufacturers to report about certain price increases for prescription drugs and biological products with a wholesale cost of at least $100 per month. Such reports must include, among other information (1) the percentage price increase, (2) a justification for such increase, (3) the price history of the drug, (4) the total cost to develop the drug, and (5) the total revenue and net profit generated from the drug.

]]> 07 2019-09-24 Reported to House 2021-09-10T20:18:28Z More Efficient Tools to Realize Information for Consumers Act or the METRIC Act

This bill requires prescription drug manufacturers to report, and the Department of Health and Human Services (HHS) to publish, specified information related to prescription drug pricing and the pharmaceutical supply chain. Specifically, HHS must publish reports submitted by drug manufacturers that include the percentage of any wholesale drug price increase that is greater than 10% in one calendar year (or 25% over three consecutive years), an explanation for the price increase, and other data. HHS must enter agreements with other agencies, research organizations, and public and private health insurers to share data submitted to HHS by drug manufacturers about the identity and quantity of drug sample requests by health practitioners.

HHS also must publish online aggregate data reported by pharmacy benefits managers (PBMs), including the percentage of prescriptions provided by mail-order, rate that generic versions of drugs are dispensed, and aggregate discounts, rebates, or price concessions negotiated.

The bill requires the Federal Trade Commission to report about potentially anticompetitive practices by PBMs such as steering patients to certain pharmacies or designing price formulas that increase the market share of higher priced drugs, among other information. The report also must include recommendations to increase transparency and deter anticompetitive behavior.

The bill further requires Medicare prescription drug plan sponsors to implement an electronic, real-time benefit tool that provides prescribers with patient-specific formulary and benefit information. Additionally, the bill expands certain price reporting requirements for prescription drug payments under Medicare.

]]> More Efficient Tools to Realize Information for Consumers Act Display Title More Efficient Tools to Realize Information for Consumers Act Official Title as Introduced To require reporting regarding certain drug price increases, and for other purposes. Reported in House RH Short Title(s) as Introduced FAIR Drug Pricing Act of 2019 Introduced in House IH Short Title(s) as Introduced Fair Accountability and Innovative Research Drug Pricing Act of 2019 Introduced in House IH Short Title(s) as Reported to House More Efficient Tools to Realize Information for Consumers Act H House Reported in House RH Reported in House 2019-09-24T04:00:00Z https://www.govinfo.gov/content/pkg/BILLS-116hr2296rh/xml/BILLS-116hr2296rh.xml Introduced in House 2019-04-12T04:00:00Z https://www.govinfo.gov/content/pkg/BILLS-116hr2296ih/xml/BILLS-116hr2296ih.xml 2019-09-24 Placed on the Union Calendar, Calendar No. 170. text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. Congressional Research Service, Library of Congress This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.